Literature DB >> 1374234

Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury.

L J Eddy1, D V Goeddel, G H Wong.   

Abstract

We have demonstrated that tumor necrosis factor-alpha (TNF-alpha) pretreatment protected the rat heart from ischemia-reperfusion injury. This effect was monitored by assaying for lactate dehydrogenase (LDH), an enzyme whose release correlates with loss of cell membrane integrity. Intact hearts removed from rats pretreated with TNF-released significantly lower amounts of LDH compared to control hearts after 20 min. of total global ischemia followed by reperfusion. Hearts from TNF-alpha-pretreated animals contained higher levels of manganous superoxide dismutase (MnSOD) mRNA than hearts from untreated rats. Because oxygen free radicals have been implicated as a major cause of reperfusion damage and the function of MnSOD is to detoxify superoxide anions in the mitochondria, a possible protective mechanism for TNF-alpha may be to induce expression of MnSOD in the heart and thus confer resistance to oxygen free radicals generated during reperfusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374234     DOI: 10.1016/0006-291x(92)90698-k

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  Inflammatory and metabolic response of the myocardium during aortic valve surgery on the beating heart.

Authors:  Mirsad Kacila; Stefano Bevilaqua; Sasha Matteucci; Marco Solinas; Andrea Farnetti; Gianetti Jacopo; Mattia Glauber
Journal:  Bosn J Basic Med Sci       Date:  2006-05       Impact factor: 3.363

2.  Cytoprotective mechanisms in cultured cardiomyocytes.

Authors:  H S Sharma; J Stahl; D Weisensee; I Löw-Friedrich
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

3.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction.

Authors:  K M Kurrelmeyer; L H Michael; G Baumgarten; G E Taffet; J J Peschon; N Sivasubramanian; M L Entman; D L Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 4.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

5.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

6.  Monophosphoryl lipid A induces pharmacologic 'preconditioning' in rabbit hearts without concomitant expression of 70-kDa heat shock protein.

Authors:  K Yoshida; M M Maaieh; J B Shipley; M Doloresco; N L Bernardo; Y Z Qian; G T Elliott; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1996-06-07       Impact factor: 3.396

7.  The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning.

Authors:  Michael P Flaherty; Yiru Guo; Sumit Tiwari; Arash Rezazadeh; Greg Hunt; Santosh K Sanganalmath; Xian-Liang Tang; Roberto Bolli; Buddhadeb Dawn
Journal:  J Mol Cell Cardiol       Date:  2008-09-12       Impact factor: 5.000

8.  Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo.

Authors:  K C Flanders; T S Winokur; M G Holder; M B Sporn
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Morphological and molecular changes of the myocardium after left ventricular mechanical support.

Authors:  Hideo A Baba; Jeremias Wohlschlaeger
Journal:  Curr Cardiol Rev       Date:  2008-08

10.  The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.

Authors:  Jana S Burchfield; Jian-Wen Dong; Yasushi Sakata; Feng Gao; Huei-Ping Tzeng; Veli K Topkara; Mark L Entman; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2009-10-30       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.